PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1674128
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1674128
Global Meningococcal Vaccines Market is estimated to be valued at USD 4.53 Bn in 2025 and is expected to reach USD 9.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 4.53 Bn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 10.40% | 2032 Value Projection: | USD 9.05 Bn |
Meningococcal disease refers to the bacterial infections causing meningitis and sepsis that can lead to serious illness or even death, if not promptly treated. Rising prevalence of these invasive meningococcal diseases along with growing awareness about the availability of effective vaccines against such infections can boost demand for meningococcal vaccines globally. Furthermore, ongoing research & development activities for new conjugate vaccines against additional serotypes and expanding vaccination programs worldwide can offer numerous opportunities for market players in the near future. However, factors such as high costs associated with vaccine development and threats of substitutes can hamper the market growth.
Global meningococcal vaccines market growth is driven by rising prevalence of invasive meningococcal diseases worldwide due to changing demographics and lifestyle patterns. According to the World Health Organization (WHO), approximately 1.2 million cases of meningococcal meningitis occur every year across the globe, leading to around 135,000 deaths. Growing initiatives by governments and health agencies to promote immunization programs against major serotypes through national vaccination schedules boosts uptake of meningococcal vaccines. Introduction of newer generation multivalent meningococcal vaccines providing protection against additional serogroups can offer opportunities for market players. However, high research and development costs associated with development of novel meningococcal vaccines along with availability of alternative treatment options can hamper the market growth.
Detailed Segmentation-